In terms of protein expression, we found that AXL was significantly up‐regulated in renal clear cell carcinoma, CD47 was significantly up‐regulated in ovarian cancer, pancreatic cancer and endometrial cancer, and MERTK was significantly up‐regulated in both ccRCC and pancreatic cancer. This evidence concerns the gene CD47 and nonpapillary renal cell carcinoma.